Purpose: To determine the functional and anatomical outcome of intravitreal Bevacizumab in patients with macular edema secondary to branch retinal vein occlusion. Study Design: Quasi Experimental study. Place and Duration of Study: Institute of Ophthalmology, Mayo hospital, Lahore, from February 2016 to December 2018. Material and Methods: Forty eyes of 40 patients with macular edema on OCT secondary to BRVO were included in the study. All the patients suffering from other types of macular edema caused by diabetes, epi-retinal membrane (ERM), surgery involving posterior segment, vitreoretinal traction and history of intravitreal VEGF or steroids were excluded from the study. Intravitreal Bevacizumab was given when macular thickness
HTML Full Text | Complete PDF